Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: PRactice of VENTilation in Patients With ARDS Due to COVID-19 vs Pneumonia
This clinical trial update reports on ventilation practices in patients with acute respiratory distress syndrome (ARDS) due to COVID-19 comp…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Clinical Evaluation of FreeO2 (Version 4) in All Patients Receiving Oxygen [NA]
Completed clinical evaluation update for the FreeO2 oxygen therapy device in patients receiving supplemental oxygen.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases
Clinical trial update reporting multiplex respiratory PCR results in pneumonia cases among individuals with diabetes.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. [Phase 3]
Phase 3 trial results for Reparixin in hospitalized patients with severe COVID-19 pneumonia have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Online Learning Portal on Under Five Pneumonia [NA]
This clinical trial update from the University of Edinburgh reports a completed study on an online learning portal for pneumonia in children…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Bacterial Pathogens Associated With Community-acquired Pneumonia in Children
A completed study examining the bacterial pathogens associated with community-acquired pneumonia in children. The trial status indicates the…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: SP16 as a Therapeutic for COVID-19 Induced ARDS [Phase 1]
Phase 1 trial of SP16 for COVID-19-induced acute respiratory distress syndrome has been terminated by Serpin Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Impact of Physical Therapy of Dysphagia on Preventing Pneumonia in Acute Stroke Patients [NA]
This completed clinical trial evaluated whether physical therapy for dysphagia could prevent pneumonia in patients with acute stroke.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) [Phase 3]
A Phase 3 trial (STRIDE-6) evaluating the safety, tolerability, and immunogenicity of the V116 pneumococcal vaccine in adults with prior pne…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure [NA]
A completed trial evaluated text message nudges delivered before primary care visits to improve closing of care gaps. The study status is co…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients [Phase 4]
Phase 4 trial exploring whether zoledronate can prevent pneumonia in patients with hip fractures.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia [EARLY_Phase 1]
Early-phase trial evaluating procalcitonin to guide antibiotic use in pediatric pneumonia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years [Phase 4]
A Phase 4 study evaluating the persistence of immunity of PCV13 in healthy children aged 2 months to 5 years, completed.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients [Phase 4]
Phase 4 trial updates the efficacy of intravenous Amboxol hydrochloride as an adjunct therapy for severe pneumonia in critically ill patient…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia [Phase 4]
Phase 4 trial comparing beta-lactam continuous versus intermittent infusion in critically ill pneumonia patients; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children [Phase 4]
Phase 4 clinical trial evaluating azithromycin to prevent post-discharge morbidity and mortality in Kenyan children.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia [Phase 3]
A Phase 3 trial comparing intravenous N-acetylcysteine plus oseltamivir versus oseltamivir alone in adults hospitalized with influenza and p…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19) [Phase 2]
Phase 2 clinical trial update for ADR-001 in patients with severe pneumonia due to SARS-CoV-2 (COVID-19) has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure [Phase 1, Phase 2]
A phase 1/2 clinical trial is investigating extracellular vesicles derived from mesenchymal cells for treating acute respiratory failure, in…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating fostamatinib for COVID-19 has completed enrollment and study status.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 [Phase 3]
A Phase 3 clinical trial comparing best supportive care with or without low-dose whole lung radiation therapy for COVID-19-related pneumonia…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating emvododstat (PTC299) for hospitalized COVID-19 pneumonia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia [Phase 4]
A Phase 4 trial comparing pristinamycin (Pyostacine) to amoxicillin for acute community-acquired pneumonia was terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis [Phase 4]
Phase 4 trial update examining oral glutamine care on oral health, microbiome, and pneumonia incidence after neurosurgery.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Anakinra in the Management of COVID-19 Infection [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating anakinra for COVID-19–related pneumonia and cytokine release syndrome.